Should FDA release info about a product that has been submitted for PMA or 510(k) but not yet approved or cleared?
By hthompson
Published: August 6, 2010
Yes, it is in the interest of public health.
9% (3 votes)
Absolutely not. It will cause competitive harm.
62% (21 votes)
Maybe, but only if the submitting company had the opportunity to redact proprietary information.
29% (10 votes)
Total votes: 34
»